Key Management

Dr Paul MacLeman

Executive Chairman 

Paul brings decades of experience across the life sciences sector, including veterinary practice, pharmaceutical development and manufacturing, biotechnology, diagnostics and finance.

He has expertise in capital raising, business development, technology commercialisation, and drug development. He has founded life sciences start-ups in the biologics area and worked in investment banking.

Previously served as Managing Director and/or CEO of several VC funded, ASX, NASDAQ and TSX listed companies. Paul is the current Chairman of AdAlta Limited (ASX:1AD). Fellow of the Australian Institute of Company Directors.

Dr David Foster

Managing Director 

Dr Foster has 20+ years experience in life sciences representing pharmaceutical, biotherapeutic and diagnostic companies, while in private legal practice.

He served as intellectual property counsel at Medarex, a mid-sized biotherapeutics company, acquired by Bristol-Myers Squibb.

Dr Foster co-founded Roberts Foster LLP - a technology focused law firm, bionorthTx- a regional life science trade association, and multiple private biotechnology companies.

He is a board member of bionorthTx and private biotechnology companies, and is a Member of Australian Institute of Company Directors.

He holds a Ph.D. from The University of Texas Southwestern Medical Center and J.D. from Golden Gate University School of Law.

Nick McCoy

Vice President Clinical Product Development 

Nick is an experienced clinical research professional with a demonstrated history working in the pharmaceutical, biotechnology and medical device industries. His experience spans multiple therapeutic areas and all phases of clinical research. He has held positions within large global organizations and smaller privately held companies, and has considerable experience managing and overseeing global clinical teams and clinical trials in numerous countries.

Prior to joining Island Pharmaceuticals, Nick was with Palisade Bio, a small biotech gastrointestinal company focused on adhesion prevention and return of bowel function following colon and rectal surgery. Prior to Palisade Bio, he spent six years at TissueTech, where he held multiple positions of ascending authority, ultimately serving as Vice President of Clinical Operations.

Nick holds a Bachelor's degree in biology from Southern Nazarene University and a Masters certificate in Clinical Research Administration from George Washington University. He also completed a post-graduate course in clinical pharmacology, drug development and regulations through Tufts University.